SCHEMBL23382495

SCHEMBL23382495

CCC(C)(C)OC(=O)c1ccc(C(=O)OCC(F)(F)C(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ SCN1A P35498 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ SCN5A Q14524 1/20 0.42
▸ SCN2A Q99250 1/20 0.42
▸ SCN3A Q9NY46 1/20 0.42
▸ MAPK1 P28482 3/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ ESR1 P03372 3/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382800 0.87 ELANE (0.43) CYP2D6TDP1HTR1ASCN1ASLC6A3
SCHEMBL23382489 0.87 MAPK1 (0.45) CYP2D6TDP1HTR1ASCN1ASLC6A3
SCHEMBL23382685 0.86 SMN1; SMN2 (0.44) CYP2D6TDP1HTR1ASCN1ASLC6A3
SCHEMBL5366422 0.81 CYP1A2 (0.49) CYP2D6TDP1MAPK1CYP1A2CYP2C19
SCHEMBL23382693 0.81 SMN1; SMN2 (0.44) CYP2D6TDP1HTR1ASCN1ASLC6A3
SCHEMBL23559376 0.80 RAB9A (0.51) TDP1MAPK1HIF1ACYP1A2PDK1
SCHEMBL20442317 0.80 CA1 (0.59) TDP1MAPK1CYP1A2PDK1PDK2
SCHEMBL24361312 0.79 ESR1 (0.53) CYP2D6TDP1MAPK1HIF1ACYP1A2
SCHEMBL23382690 0.78 TP53 (0.47) CYP2D6TDP1HTR1ASCN1ASLC6A3
SCHEMBL12638979 0.78 ALDH1A1 (0.52) CYP2D6CYP1A2CYP2C19CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 CYP2D6 3075/4885TDP1 4190/4885HTR1A 4571/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 CYP2D6 3075/4885TDP1 4190/4885HTR1A 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback